Your browser doesn't support javascript.
loading
Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
Cancer Res ; 67(11): 5300-7, 2007 Jun 01.
Article in En | MEDLINE | ID: mdl-17545610
Search on Google
Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Fusion Proteins, bcr-abl / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Immunotherapy Limits: Humans Language: En Year: 2007 Type: Article
Search on Google
Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Fusion Proteins, bcr-abl / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Immunotherapy Limits: Humans Language: En Year: 2007 Type: Article